ArticleOncotarget2017
NOD2 maybe a biomarker for the survival of kidney cancer patients.
Deguo Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncotarget2017
Deguo Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.